Prevalence of hyperhomocysteinemia in vascular disease: Comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease

Vascular

Volumn 15, Issue 3, 2007, Pages 149-153

  Bhargava, Seema ^a   Parakh, Rajiv ^a   Manocha, Anjali ^a   Ali, Arif ^b   Srivastava, Lalit Mohan ^a  

^a SIR GANGA RAM HOSPITAL   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Arterial occlusion; Hyperhomocysteinemia; Vascular risk factor; Venous thrombosis

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CHEMOLUMINESCENCE; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLOW UP; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNOASSAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; URBAN POPULATION; VASCULAR DISEASE; VEIN DISEASE; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; ARTERIAL OCCLUSIVE DISEASES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INDIA; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RISK FACTORS; URBAN HEALTH; VENOUS THROMBOSIS; VITAMIN B COMPLEX;

EID: 34548045763     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2007.00031     Document Type: Article

References (19)

1. Schoen FJ. Blood vessels. In: Kumar V, Abbas AK, Sausto N, editors. Robbins and Cotran pathologic basis of disease. Philadelphia, Pennsylvania: Elsevier (Saunders); 2004. p. 511-54.
2. Sidawy AN, Mitchell ME. Basic considerations of arterial wall in health and disease. In: Rutherford RB, editor. Vascular surgery, 5th ed. Philadelphia: WB Saunders; 2000. p. 60-72.
3. Meissner MH, Strandness DE. Pathophysiology and natural history of acute DVT. In: Rutherford RB, editor. Vascular surgery, 5th ed. Philadelphia: WB Saunders; 2000. p. 1920-37.
4. Cook DJ, Crowther MA, Meade MO, Douketis J. Prevalence, incidence and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. J Crit Care 2005;20: 309-13.
5. Bhargava S, Parakh R, Srivastava LM. Prevalence and treatment of hyperhomocysteinemia in occlusive vascular disease. Trends in Clinical Biochemistry and Laboratory Medicine: Proceeds of the 9th APFCB (Asian Pacific Federation of Clinical Biochemistry) 2003. p. 150-6.
6. Bhargava S, Srivastava LM. Homocysteine - marker of the millenium, a review of its evolution and clinical implication. J Med Sci 2001;4:104-16.
7. Boushey CJ, Beresford SA, Omen GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 2000;274:1049-57.
8. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999;19:217-46.
9. Heinecke JW. Unique aspects of sulphur chemistry: homocysteine and lipid oxidation. In: Jacobsen DW, Carmel R, editors. Homocysteine in health and disease. Cambridge, UK: Cambridge University Press; 2001. p. 32-3.
10. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-28.
11. Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlations with cobalamin and folate levels in healthy subjects. Clin Chem 1994;40:873-81.
12. Mayer EM, Jacobsen DW, Robinsen K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27:517-27.
13. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-55.
14. Robinson K, Mayer EL, Miller DP, et al. Hyperhomocysteinemia and low pyridoxal phosphate - common and independent reversible factors for coronary artery disease. Circulation 1995;92:2825-30.
15. de Luis DA, Fernandez N, Arranz ML, et al. Total homocysteine levels relation with chronic complication of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. J Diabet Complications 2005;19:42-6.
16. Herrmann W. Significance of hyperhomocysteinemia. Clin Lab 2006;52:367-74.
17. Tan KJ, Chow PKH, Tan YM, Thng CH. Portal vein thrombosis secondary to hyperhomocysteinemia: a case report. Dig Dis Sci 2006;51:1218-20.
18. 12 in urban North India. Eur J Nutr 2002;41:68-77.
19. Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.